Revolution Medicines RVMDW
NASDAQ RVMDW
$10.25 +0.62 (+6.44%)
As of: Nov 3, 2026 · 10:36 AM EST

Revolution Medicines (RVMDW) Change in Receivables (2020 - 2024)

Updated

Revolution Medicines' Change in Receivables was -$1.25 million in FY2024, compared with -$3.42 million in FY2023.

Analysis

Revolution Medicines (RVMDW) Change in Receivables (2020 - 2024) Analysis & Trends

From FY2019 onward, Revolution Medicines has reported Change in Receivables for 6 years.

  • The FY2024 figure marks the highest annual Change in Receivables since FY2021.
  • Per Business Quant data, Change in Receivables in earlier years was -$3.42 million in FY2023, -$1.26 million in FY2022, -$464,000 in FY2021 and -$2.34 million in FY2020.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -1.25 Mn
Dec 31, 2023 945,000.00
Sep 30, 2023 -2.20 Mn
Jun 30, 2023 -1.49 Mn
Mar 31, 2023 -678,000.00
Dec 31, 2022 -267,000.00
Sep 30, 2022 -684,000.00
Jun 30, 2022 241,000.00
Mar 31, 2022 -546,000.00
Dec 31, 2021 -1.48 Mn
Sep 30, 2021 885,000.00
Jun 30, 2021 -1.04 Mn
Mar 31, 2021 1.17 Mn
Dec 31, 2020 -2.91 Mn
Sep 30, 2020 1.97 Mn
Jun 30, 2020 -1.12 Mn
Mar 31, 2020 -287,000.00
API Access

Revolution Medicines Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=RVMDW&period=max&api_key=YOUR_API_KEY